Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Overview of soft tissue rheumatic disorders

Irving Kushner, MD
Section Editor
Zacharia Isaac, MD
Deputy Editor
Monica Ramirez Curtis, MD, MPH


Soft tissue rheumatic disorders refer to nonsystemic, focal pathologic syndromes involving the periarticular tissues, including muscle, tendon, ligament, fascia, aponeurosis, retinaculum, bursa, and subcutaneous tissue. These disorders are extremely common. The archaic term "rheumatism" is sometimes used to refer to these manifestations.

Although soft tissue rheumatic disorders refer to nonarticular pain, patients often attribute their symptoms to nearby joints. Thus, when patients complain of hip pain, the cause is often not pain in the joint itself, but rather in the "hip region": the groin, buttock, upper lateral thigh, greater trochanteric area, and iliac crest. Similarly, complaints of elbow, wrist, knee, and shoulder pain frequently mean pain in the general region of those joints, and may reflect soft tissue lesions such as epicondylitis, tenosynovitis, and bursitis.

Soft tissue disorders may be divided into several broad categories and include:



To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: May 12, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003; 36:1404.
  2. Marie I, Delafenêtre H, Massy N, et al. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum 2008; 59:367.
  3. Beri A, Dwamena FC, Dwamena BA. Association between statin therapy and tendon rupture: a case-control study. J Cardiovasc Pharmacol 2009; 53:401.
  4. Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001; 199:503.
  5. de Miguel E, Muñoz-Fernández S, Castillo C, et al. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. Ann Rheum Dis 2011; 70:434.
  6. Eder L, Barzilai M, Peled N, et al. The use of ultrasound for the assessment of enthesitis in patients with spondyloarthritis. Clin Radiol 2013; 68:219.
  7. Aaron DL, Patel A, Kayiaros S, Calfee R. Four common types of bursitis: diagnosis and management. J Am Acad Orthop Surg 2011; 19:359.
  8. Raskin RJ, Lawless OJ. Articular and soft tissue abnormalities in a "normal" population. J Rheumatol 1982; 9:284.
  9. Stanton-Hicks M, Jänig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995; 63:127.
  10. Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 2011; 25:185.
  11. Yap EC. Myofascial pain--an overview. Ann Acad Med Singapore 2007; 36:43.
  12. Travell, JG, Simons, DG. Myofascial Pain and Dysfunction. The Trigger Point Manual: Upper Half of Body, 2nd edition. Lippincott, Williams & Wilkins, Baltimore 1988.
  13. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med 1989; 151:157.
  14. Ettlin T, Schuster C, Stoffel R, et al. A distinct pattern of myofascial findings in patients after whiplash injury. Arch Phys Med Rehabil 2008; 89:1290.
  15. Couppé C, Torelli P, Fuglsang-Frederiksen A, et al. Myofascial trigger points are very prevalent in patients with chronic tension-type headache: a double-blinded controlled study. Clin J Pain 2007; 23:23.
  16. Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Phys Med Rehabil Clin N Am 2006; 17:491.
  17. Fernández-de-Las-Peñas C, Alonso-Blanco C, Cuadrado ML, et al. Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 2006; 46:1264.
  18. Wigley R. Can fibromyalgia be separated from regional pain syndrome affecting the arm? J Rheumatol 1999; 26:515.
  19. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62:600.
  20. Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep 2006; 10:345.
  21. Atcheson SG, Ward JR, Lowe W. Concurrent medical disease in work-related carpal tunnel syndrome. Arch Intern Med 1998; 158:1506.
  22. Nadler SF, Weingand K, Kruse RJ. The physiologic basis and clinical applications of cryotherapy and thermotherapy for the pain practitioner. Pain Physician 2004; 7:395.
  23. French SD, Cameron M, Walker BF, et al. A Cochrane review of superficial heat or cold for low back pain. Spine (Phila Pa 1976) 2006; 31:998.
  24. Brosseau L, Yonge KA, Robinson V, et al. Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev 2003; :CD004522.
  25. Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18:297.
  26. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003; 106:151.
  27. Micu MC, Alcalde M, Sáenz JI, et al. Impact of musculoskeletal ultrasound in an outpatient rheumatology clinic. Arthritis Care Res (Hoboken) 2013; 65:615.
  28. McEvoy JR, Lee KS, Blankenbaker DG, et al. Ultrasound-guided corticosteroid injections for treatment of greater trochanteric pain syndrome: greater trochanter bursa versus subgluteus medius bursa. AJR Am J Roentgenol 2013; 201:W313.
  29. Hadduck TA, van Holsbeeck MT, Girish G, et al. Value of ultrasound before joint aspiration. AJR Am J Roentgenol 2013; 201:W453.
  30. Lang AM. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review. Clin Ther 2003; 25:2268.
  31. De Andrés J, Cerda-Olmedo G, Valía JC, et al. Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain 2003; 19:269.
  32. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000; 85:101.
  33. Qerama E, Fuglsang-Frederiksen A, Kasch H, et al. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 2006; 67:241.
  34. Kamanli A, Kaya A, Ardicoglu O, et al. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005; 25:604.
  35. Graboski CL, Gray DS, Burnham RS. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain 2005; 118:170.